These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26771719)

  • 1. New developments with drug-coated balloons.
    Tepe G
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):1-2. PubMed ID: 26771719
    [No Abstract]   [Full Text] [Related]  

  • 2. What are the potential limitations of drug coated balloons and possible ways to overcome.
    Werk M
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-coated balloons: what is the evidence?
    Marques L; Hopf-Jensen S; Müller-Hülsbeck S
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):12-7. PubMed ID: 26771721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug coated balloons below-the-knee: just too early?
    Fanelli F; Cannavale A
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):18-22. PubMed ID: 26771722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does a drug-coated balloon work? Overview of coating techniques and their impact.
    Speck U; Stolzenburg N; Peters D; Scheller B
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):3-11. PubMed ID: 26771720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries.
    Freyhardt P; Zeller T; Kröncke TJ; Schwarzwaelder U; Schreiter NF; Stiepani H; Sixt S; Rastan A; Werk M
    Rofo; 2011 May; 183(5):448-55. PubMed ID: 21274828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in below-the-knee drug-eluting balloons.
    Ferraresi R; Centola M; Biondi-Zoccai G
    J Cardiovasc Surg (Torino); 2012 Apr; 53(2):205-13. PubMed ID: 22456643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
    Vaquerizo B; Serra A; Miranda-Guardiola F; Martínez V; Antoni Gómez-Hospital J; Iñiguez A; Fernández E; Ramón Rumoroso J; Bosa F; Otaegui I
    J Interv Cardiol; 2011 Dec; 24(6):518-28. PubMed ID: 21917013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions.
    Loh JP; Waksman R
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1001-12. PubMed ID: 23078727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery at the aortic valve tissues of healthy domestic pigs with a Paclitaxel-eluting valvuloplasty balloon.
    Spargias K; Milewski K; Debinski M; Buszman PP; Cokkinos DV; Pogge R; Buszman P
    J Interv Cardiol; 2009 Jun; 22(3):291-8. PubMed ID: 19490359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla.
    Neizel M; Ruebben A; Weiss N; Günther RW; Kelm M; Krombach GA
    Rofo; 2014 Apr; 186(4):388-93. PubMed ID: 24142436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
    Ju MH; Rodríguez HE
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloons for restenosis prophylaxis.
    Speck U; Scheller B; Hamm B
    Rofo; 2014 Apr; 186(4):348-58. PubMed ID: 23999788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-coated balloon angioplasty for lower extremity revascularization: a new way to fight in-stent restenosis.
    Manzi M; Cester G; Palena LM
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):567-71. PubMed ID: 20671641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral applications of drug-coated balloons: past, present and future.
    Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-coated balloons and their place in treating peripheral arterial disease.
    Schnorr B; Albrecht T
    Expert Rev Med Devices; 2013 Jan; 10(1):105-14. PubMed ID: 23278227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-coated balloons - Survey of preclinical data.
    Schnorr B; Kelsch B; Cremers B; Clever YP; Speck U; Scheller B
    Minerva Cardioangiol; 2010 Oct; 58(5):567-82. PubMed ID: 20948503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.